Navigation Links
LifeSpan Adds 1,200+ New Antibodies To Its Proprietary IHC-plus(TM) Product Line
Date:1/29/2013

SEATTLE, Jan. 29, 2013 /PRNewswire/ -- LifeSpan BioSciences, Inc. (LSBio), the world's leading provider of high quality, immunohistochemistry (IHC) validated research antibodies, announced today that it has added more than 1,200 proprietary IHC-plus™ antibodies to its catalog.  The additions include a collection of nearly 900 antibodies targeting G Protein-Coupled Receptors (GPCRs), an important family of proteins that are the targets for nearly one-third of all pharmaceutical drugs currently on the market.  In 2012, the Nobel Prize for Chemistry was awarded to Robert Lefkowitz and Brian Kobilka for their pioneering studies of GPCRs and research interest in these potential drug targets has been high.  Also added were antibodies to a variety of protein kinases, ion channel and nuclear receptors that are also of particular interest to researchers around the world.  All of these antibodies were developed by LSBio for major pharmaceutical and biotech customers and are now available online and through an international network of highly respected distributors.

With this increase, LSBio may now control the most extensive collection of IHC validated antibodies to the GPCR family and is well on its way to achieving its goal of building the world's largest catalog of value added reagent antibodies for use in IHC.  LSBio's catalog currently contains more than one hundred thousand antibodies that may be used in various types of assays and roughly 10% of these are in the IHC-plus product line. 

Immunohistochemistry (IHC) has proven to be especially valuable in preclinical studies of new drugs. Researchers in pharmaceutical and biotech companies, and in academia, are increasingly relying on IHC to establish the presence or absence of drug targets in diseased and normal tissues, helping to predict the
'/>"/>

SOURCE LifeSpan BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cancer Antibodies: Drug Target Atlas and Competitive Outlook
2. X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHIs Protein Engineering Summit
3. Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
4. GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly
5. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
6. WaferGens MyDesign Open Platform Facilitates Rapid Development of a Proprietary Prostate Cancer Diagnostic Panel in the Lab of Dr. Arul Chinnaiyan at the University of Michigan Cancer Center
7. New Report: "Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance" Now Available at Twease.org
8. Lixte Biotechnology Receives US Patent for Its Proprietary Histone Deacetylase Inhibitor
9. Cenestra Health Announces Granting of Broad Patent Covering Proprietary Bioactive Lipid Formulations
10. Omaha Residents May See A Frightening Bed Bug Epidemic, MyCleaningProducts.com Offers Non Pesticide Treatment To Aid Victims
11. Topricin Pain Relief and Healing Cream Selected by Healthy Holistic Living as one of the Top 100 Green Products of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... PARK, Calif. , Aug. 28, 2014 /PRNewswire/ ... focused on developing novel mid- to late-stage cardiovascular ... $7.0 million in its first round of financing. ... Biomedical Investments and Hercules Bioventures with participation from ... entrepreneur and pharmaceutical executive, Dr. Larry Hsu ...
(Date:8/28/2014)... Vt. (PRWEB) August 28, 2014 ... testing around the world is available from Strategic ... diagnostics companies. “ Industrial Microbiology Market Review, Fourth ... Industrial Market ” (IMMR—4) tracks and compares microbiology ... in North America, Europe and Asia, and forecasts ...
(Date:8/28/2014)... 2014 Supplementing their complete line ... for Eppendorf Safe Lock Centrifuge Tubes . ... highest quality tubes at an affordable price. Eppendorf ... doing chemical, medical, pharmaceutical, and life science research ... regularly able to afford Eppendorf products. , Eppendorf ...
(Date:8/27/2014)... Green & Grow Inc. (GGI) has ... and secured Otter Capital as a significant new partner. ... of GGI’s Agriplier™ technology, building on recent compelling field ... our first meeting, we have been impressed with Otter ... said Alan Sobba, President and CEO of GGI. “We ...
Breaking Biology Technology:Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3
... Mass. and SAN DIEGO, Calif., April 16 ,Boston ... Inc. (Nasdaq: CRYO ),today announced the signing ... will pay a cash purchase price of $1.35 ... acquisition follows a,development agreement, in place since June ...
... the 99th Annual Meeting of the American ... Association for Cancer Research (AACR) ... Inc.,("Lorus") (TSX: LOR; AMEX: LRP), a biopharmaceutical company specializing,in ... for the management of cancer, today announced,presentations of further ...
... Serono and its US,affiliate EMD Serono, Inc., both ... planned expansion of EMD Serono,s US presence with ... facility northwest,of Boston, Massachusetts. The company anticipates that ... in Massachusetts., The investment will support the ...
Cached Biology Technology:Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 2Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 3Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 4Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 5Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 6Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040 2Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040 3Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040 4EMD Serono Announces Planned Investment of $50 Million in Research Center in Massachusetts 2EMD Serono Announces Planned Investment of $50 Million in Research Center in Massachusetts 3EMD Serono Announces Planned Investment of $50 Million in Research Center in Massachusetts 4
(Date:8/28/2014)... FASEB MARC (Maximizing Access to Research Careers) Program ... American College of Sports Medicine,s Conference on Integrative ... Miami, Florida. These awards are meant to ... scientists from underrepresented groups into the mainstream of ... participation of young scientists at the American College ...
(Date:8/28/2014)... measuring and imaging how quickly blood flows in the ... drug abuse affects the brain, which may aid in ... better treatment options for recovering drug addicts. The new ... Brook University in New York, USA and the U.S. ... Optical Society,s (OSA) open-access journal Biomedical Optics ...
(Date:8/28/2014)... 25 million kilometres of new roads will be built ... into Earth,s last wildernesses, where they bring an influx ... Now, an ambitious study has created a ,global roadmap, ... to balance the competing demands of development and environmental ... layer that estimates that natural importance of ecosystems and ...
Breaking Biology News(10 mins):This is your brain's blood vessels on drugs 2This is your brain's blood vessels on drugs 3Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3
... Livermore National Laboratory physicist and his colleagues have found ... used in physics to help solve problems in biology. ... modeling to shed light on something known as epigenetic ... memory of some variable condition, such as quality of ...
... had been reckoned until today to be around 2,000 million ... fish, in other words, ones found at depths of between ... international team*, in which AZTI-Tecnalia researchers are participating and which ... has discovered that its abundance could be at least 10 ...
... by excessive and systemic reaction of the entire body ... The number of deaths by septic shock in intensive ... despite numerous large scale clinical trials. Scientists of VIB ... mouse study that a potential novel treatment for sepsis ...
Cached Biology News:New application of physics tools used in biology 2Researchers at UGent and VIB, discovered potential novel treatment against septic shock 2
...
cysteine and glycine-rich protein 2,...
... Antitumour agent and DNA-topoisomersae II inhibitor (IC50 = ... C 29 H 32 O 13 ... Store at: RT ... Solubility: Soluble to 100 ...
HSPBP1 Antibody...
Biology Products: